Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-24-038815
Filing Date
2024-09-30
Accepted
2024-09-30 16:53:17
Documents
82
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 2530619
2 ex31-1.htm EX-31.1 12219
3 ex31-2.htm EX-31.2 12867
4 ex32-1.htm EX-32.1 6304
5 logo_001.jpg GRAPHIC 68479
  Complete submission text file 0001493152-24-038815.txt   12453088

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE ppcb-20240630.xsd EX-101.SCH 76955
7 XBRL CALCULATION FILE ppcb-20240630_cal.xml EX-101.CAL 82328
8 XBRL DEFINITION FILE ppcb-20240630_def.xml EX-101.DEF 378568
9 XBRL LABEL FILE ppcb-20240630_lab.xml EX-101.LAB 619525
10 XBRL PRESENTATION FILE ppcb-20240630_pre.xml EX-101.PRE 505890
85 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 1851614
Mailing Address 302/6 BUTLER STREET CAMBERWELL, VICTORIA C3 3124
Business Address 302/6 BUTLER STREET CAMBERWELL, VICTORIA C3 3124 61-03-9882-0780
Propanc Biopharma, Inc. (Filer) CIK: 0001517681 (see all company filings)

EIN.: 330662986 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 000-54878 | Film No.: 241340132
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)